Clinical Trial: A Study of LY3871801 in Healthy Asian and Non-Asian Participants
Study Status: ACTIVE_NOT_RECRUITING
Recruit Status: ACTIVE_NOT_RECRUITING
Condition: Healthy
Study Type: INTERVENTIONAL
Official Title: A Phase I, Participant- and Investigator-Blind, Single-center Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of LY3871801 in Healthy Asian and Non-Asian Particip
Brief Summary:
The main purpose of this study is to evaluate the safety and tolerability of LY3871801 when administered as multiple doses in Healthy Asian and Non-Asian Participants.The study will also evaluate the amount of LY3871801 that gets into the blood stream and how long it takes the body to get rid of it in these participants.The study will be conducted in two parts (A & B).The study will last up to approximately 24 days excluding the screening period.
Read more